| Date | Company | Research Firm | Rating |
|
|
STC | AlphaMena | Aggregate |
|
|
SAB | QNB | Overweight |
|
|
STC | Citi Bank Group | Neutral |
|
|
BINDAWOOD | Goldman Sachs | Neutral |
|
|
STC | Goldman Sachs | Neutral |
| Company / Shareholder | Current Holding | Prev. Holding | Change | Note |
|---|---|---|---|---|
|
Methanol Chemicals Co.
FATIN SALEH ABDULAAZIZ AL-RAJIHI
|
6.95% | 6.87% | 0.08% | |
|
Knowledge Tower Trading Co.
Abdul Malik Ali Abdulaziz Al Masoud
|
31.09% | 31.03% | 0.06% | |
|
Mohammed Hasan AlNaqool Sons Co.
Bati Rajih Abdullah Al-Subaie
|
5.64% | 5.61% | 0.03% |
| Fund | NAV | YTD Return | |
|---|---|---|---|
| YAQEEN Gold Fund | 3,131,092.00 | 53.91% | |
| SNB Capital China Equity Fund | 9,762,499.00 | 29.80% | |
| SNB Capital Emerging Markets Index Fund | 124,693,391.00 | 27.15% | |
| ALINMA EMERGING MARKETS FUND | 55,631,251.00 | 23.18% | |
| SNB Capital Global Equity Fund | 5,426,724.00 | 20.40% | |
| AlJazira International Equities Fund | 135,342,415.00 | 18.65% | |
| SNB Capital North America Index Fund | 854,472,580.00 | 18.19% | |
| SAB Invest Global Equity Index Fund | 46,941,094.00 | 18.17% | |
| SNB Capital Europe Index Fund | 161,898,796.00 | 17.78% | |
| SNB Capital Global Healthcare Fund | 47,860,975.00 | 17.53% | |
